PTX 4.44% 4.3¢ prescient therapeutics limited

FDA Approval for Amgen’s Lumakras (sotorasib), a novel KRAS inhibitor, page-9

  1. 2,593 Posts.
    lightbulb Created with Sketch. 419
    I've held PTX for a while now in my SMSF, added more the other day when it dropped, added more yesterday. PTX will, IMO continue to hit targets, and head up. This sp is a drop in the ocean, for what will be the sp down the line.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.